Skip to main content
Log in

Growth hormone cotreatment with gonadotropins in ovulation induction

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Sheikholislam B.M., Stempfei R.S. jr. Hereditary isolated somatotropin deficiency: effects of human growth hormone deficiency administration. Pediatrics 49: 362, 1972.

    PubMed  CAS  Google Scholar 

  2. Ramaley JA, Phares C.K. Delay of puberty onset in females due to suppression of growth hormone. Endocrinology 106: 1989, 1980.

    PubMed  CAS  Google Scholar 

  3. Darendeliler F., Hindmarsh P.C., Preece M.A., Cox L, Brook CD. Growth hormone increases rate of pubertal maturation. Acta Endocrinol. (Copenh.) 122: 414, 1990.

    CAS  Google Scholar 

  4. Laron Z., Sarel R., Pertzelan A. Puberty in Laron type dwarfism. Eur. J. Pediatr. 134: 79, 1980.

    PubMed  CAS  Google Scholar 

  5. Advis J.P., Smith-White S., Ojeda S.R. Activation of growth hormone short loop negative feedback delays puberty in the female rat. Endocrinology 108: 1343, 1981.

    PubMed  CAS  Google Scholar 

  6. Menashe Y., Sack J., Mashiach S. Spontaneous pregnancies in two women with Laron-type dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation? Hum. Reprod. 6: 670, 1991.

    PubMed  CAS  Google Scholar 

  7. Moretti C, Fabbri A., Gnessi L, Bonifacio V., Bolotti M., Arizzi M., Nazzicone Q., Spera G. Immunohistochemical localization of growth hormone releasing hormone in human gonads. J. Endocrinol. Invest. 13: 301, 1990.

    PubMed  CAS  Google Scholar 

  8. Moretti C, Bagnato A., Solan N., Frajese G., Catt K.J. Receptor-mediated actions of growth hormone releasing factor on granulosa cell differentiation. Endocrinology 127: 2117, 1990.

    PubMed  CAS  Google Scholar 

  9. Bagnato A., Moretti C, Frajese G., Catt K.J. Gonadotropin-induced expression of receptors for growth hormone releasing factor in cultured granulosa cells. Endocrinology 128: 2889, 1991.

    PubMed  CAS  Google Scholar 

  10. Katz E., Ricciarelli E., Adashi E.Y. The potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil. Steril. 59: 8, 1993.

    PubMed  CAS  Google Scholar 

  11. Doldi N., Bassan M., Bonzi V., Ferrari A. Effects of growth hormone and growth hormone-releasing hormone on steroid synthesis in cultured human luteinizing granulosa cells. Gynecol. Endocrinol. 10: 101, 1996.

    PubMed  CAS  Google Scholar 

  12. Nakajin S., Shinoda M., Hall P.F. C21 steroid side chain cleavage enzyme from porcine adrenal microsomes. Purification and characterization of the 17-hydroxylase/C17.20-lyase cytochrome P450. J. Biol. Chem. 259: 3971, 1984.

    PubMed  CAS  Google Scholar 

  13. Spicer L.J., Langhout D.J., Alpizar E., Williams S.K., Campbell R.M., Mowles T.F., Enright W.J. Effects of growth hormone-releasing factor and vasoactive intestinal peptide on proliferation and steroidogenesis of bovine granulosa cells. Mol. Cell. Endocrinol. 83: 73, 1992.

    PubMed  CAS  Google Scholar 

  14. Arán B., Calderón G., Moragas M., Torelló M.J., Veiga A., Barri P.N. Chromosome anomalies in mouse zygotes treated by growth hormone-releasing factor. Hum. Reprod. 7: 1394, 1992.

    PubMed  Google Scholar 

  15. Kaganowicz A., Farkouh N.H., Frantz A.G., Blaustein A.U. Ectopic human growth hormone in ovaries and breast cancer. J. Clin. Endocrinol. Metab. 48: 5, 1979.

    PubMed  CAS  Google Scholar 

  16. Davies T.F., Katikineni M., Chan V., Harwood J.P.. Dufau M.L., Catt K.J. Lactogenic receptor regulation in hormone-stimulated steroidogenic cells. Nature 283: 863, 1980.

    PubMed  CAS  Google Scholar 

  17. Ranke M.B., Stanley C.A., Tenore A., Rodbard D., Bongiovanni A.M., Parks J.S. Characterization of somatogenic and lactogenic binding sites in isolated rat hepatocytes. Endocrinology 99: 1033, 1976.

    PubMed  CAS  Google Scholar 

  18. Lobie P.E., Breipohl W., Aragon J.G., Waters M.J. Cellular localization of the growth hormone receptor/binding protein in the male and female reproductive systems. Endocrinology 126: 2214, 1990.

    PubMed  CAS  Google Scholar 

  19. Lobie P.E., Garcia-Aragon J., Wang B.S., Baumbach W.R., Waters M.J. Cellular localization of the growth hormone binding protein in the rat. Endocrinology 130: 3057, 1992.

    PubMed  CAS  Google Scholar 

  20. Jia X.-C, Kalmijn J., Hsueh A.J.W. Growth hormone enhances follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells. Endocrinology 118: 1401, 1986.

    PubMed  CAS  Google Scholar 

  21. Hsu C.-J., Hammond J.M. Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine granulosa cells. Endocrinology 121: 1343, 1987.

    PubMed  CAS  Google Scholar 

  22. Mason H.D., Martikainen H., Beard R.W., Anyaoku V., Franks S. Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells. J. Endocrinol. 126: R1–R4, 1990.

    PubMed  CAS  Google Scholar 

  23. Barreca A., Minuto F., Volpe A., Cecchelli E., Cella F., Del Monte P., Artini P., Giordano G. Insulin-like growth factor-l (IGF-I) and IGF-I binding protein in the follicular fluids of growth hormone treated patients. Clin. Endocrinol. (Oxf.) 32: 497, 1990.

    CAS  Google Scholar 

  24. Barreca A., Artini P.G., Del Monte P., Ponzani P., Pasquini P., Cariola G., Volpe A., Genazzani A.R., Giordano G., Minuto F. In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells. J. Clin. Endocrinol. Metab. 77: 61, 1993.

    PubMed  CAS  Google Scholar 

  25. El-Roeiy A., Chen X., Roberts V.J., Shimasaki S., Ling N., LeRoith D., Roberts C.T. jr., Yen S.S.C Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins 1–6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J. Clin. Endocrinol. Metab. 78: 1488, 1994.

    PubMed  CAS  Google Scholar 

  26. Lanzone A., Di Simone N., Castellani R., Fulghesu A.M., Caruso A., Mancuso S. Human growth hormone enhances progesterone production by human luteal cells in vitro: evidence of a synergistic effect with human chorionic gonadotropin. Fertil. Steril. 57: 92,1992.

    PubMed  CAS  Google Scholar 

  27. Hernandez E.R., Roberts CT., Hurwitz A., LeRoith D., Adashi E.Y. Rat ovarian insulin-like growth factor II gene expression is theca-interstitial cell-exclusive: hormonal regulation and receptor distribution. Endocrinology 127: 3249, 1990.

    PubMed  CAS  Google Scholar 

  28. Geisthovel F., Moretti-Rojas I., Asch R.H., Rojas F.J. Expression insulin-like growth factor-ll (IGF-II) messenger ribonucleic acid (mRNA), but not IGF-I mRNA, in human preovulatory granulosa cells. Hum. Reprod. 4: 899, 1989.

    PubMed  CAS  Google Scholar 

  29. Poretsky L, Kalin M.F. The gonadotropic function of insulin. Endocr. Rev. 8: 132, 1987.

    PubMed  CAS  Google Scholar 

  30. Erickson G.F., Garzo V.G., Magoffin D.A. Insulin-like growth factor-l regulates aromatase activity in human granulosa and granulosa luteal cells. J. Clin. Endocrinol. Metab. 69: 716, 1989.

    PubMed  CAS  Google Scholar 

  31. Christman G.M., Halme J.K. Growth hormone: revisited. Fertil. Steril. 57: 12, 1992.

    PubMed  CAS  Google Scholar 

  32. Bergh C, Olsson J.-H., Hillensjö T. Effect of insulin-like growth factor I on steroidogenesis in cultured human granulosa cells. Acta Endocrinol. (Copenh.) 125: 177, 1991.

    CAS  Google Scholar 

  33. Adashi E.Y., Resnick CE., D’Ercole A.J., Svoboda M.E., Van Wyk J.J. Insulin-like growth factors as ovarian regulators of granulosa cell growth and function. Endocr. Rev. 6: 400, 1985.

    PubMed  CAS  Google Scholar 

  34. Zapf J., Rinderknecht E., Humbel R.E., Froesch E.R. Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications. Metabolism 27: 1803, 1978.

    PubMed  CAS  Google Scholar 

  35. Phillips L.S., Vassilopoulou-Sellin R. Somatomedins. N. Engl. J. Med. 302: 371, 1980.

    PubMed  CAS  Google Scholar 

  36. Davoren J.B., Hsueh A.J.W. Growth hormone increases ovarian levels of immunoreactive somatomedin C/insulin-like growth factor I in vivo. Endocrinology 118: 888, 1986.

    PubMed  CAS  Google Scholar 

  37. Homburg R., West C, Torresani T., Jacobs H.S. Cotreatment with human growth hormone and gonadotropins for induction of ovulation: a controlled clinical trial. Fertil. Steril. 53: 254, 1990.

    PubMed  CAS  Google Scholar 

  38. Owen E.J., Torresani T., West C, Mason B.A., Jacobs H.S. Serum and follicular fluid insulin like growth factors I and II during growth hormone cotreatment for invitro fertilization and embryo transfer. Clin. Endocrinol. (Oxf.) 35: 327, 1991.

    CAS  Google Scholar 

  39. Davoren J.B., Hsueh A.J.W., Li CH. Somatomedin C augments FSH-induced differentiation of cultured rat granulosa cells. Am. J. Physiol. 249: E26, 1985.

    PubMed  CAS  Google Scholar 

  40. Blumenfeld Z. Growth hormone—A cogonadotropin? Its role in ovulation induction. J. In Vitro Fert. Embryo Transfer 8: 127, 1991.

    CAS  Google Scholar 

  41. Balboni G.C, Vannelli G.B., Barni T., Orlando C, Serio M. Transferrin and somatomedin C receptors in the human ovarian follicles. Fertil. Steril. 48: 706, 1987.

    Google Scholar 

  42. Gates G.S., Bayer S., Siebel M., Poretsky L, Flier J.S., Moses A.C. Characterization of insulin-like growth factor binding to human granulosa cells obtained during in-vitro fertilization. J. Recept. Res. 7: 885, 1987.

    PubMed  CAS  Google Scholar 

  43. Hsu C.-J., Hammond J.M. Gonadotropin and estradiol stimulate immunoreactive insulin-like growth factor-l production by porcine granulosa cells in vitro. Endocrinology 120: 198, 1987.

    PubMed  CAS  Google Scholar 

  44. Mondschein J.S., Hammond J.M. Growth factors regulate immunoreactive insulin-like growth factor-l production by cultured porcine granulosa cells. Endocrinology 123: 463, 1988.

    PubMed  CAS  Google Scholar 

  45. Apa R., Di Simone N., Ronsisvalle E., Miceli F., de Feo D., Caruso A., Lanzone A., Mancuso S. Insulin-like growth factor (IGF)-I and IGF-II stimulate progesterone production by human luteal cells: role of IGF-I as mediator of growth hormone action. Fertil. Steril. 66: 235, 1996.

    PubMed  CAS  Google Scholar 

  46. Mondschein J.S., Canning S.F., Miller D.Q., Hammond J.M. Insulin-like growth factors (IGFs) as autocrine/paracrine regulators of granulosa cell differentiation and growth: studies with a neutralizing monoclonal antibody to IGF-I. Biol. Reprod. 47: 79, 1989.

    Google Scholar 

  47. Voutilainen R., Miller W.L. Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain cleavage enzyme, P-450ssc, in human steroidogenic tissue. Proc. Natl. Acad. Sei. USA 84: 1590, 1987.

    CAS  Google Scholar 

  48. Ramasharma K., Li CH. Human pituitary and placental hormone control of human insulin-like growth factor II secretion in human granulosa cells. Proc. Natl. Acad. Sei. USA 84: 2643, 1987.

    CAS  Google Scholar 

  49. Ramasharma K., Cabrera CM., Li CH. Identification of insulin-like growth factor-ll in human seminal and follicular fluids. Biochem. Biophys. Res. Commun. 140: 536, 1986.

    PubMed  CAS  Google Scholar 

  50. Friedman A.J., Rein M.S., Pandian M.R., Barbieri R.L. Fasting serum growth hormone insulin-like growth factor-l and -II concentrations in women with leiomyomata uteri treated with leuprolide acetate or placebo. Fertil. Steril. 53: 250, 1990.

    PubMed  CAS  Google Scholar 

  51. Carlsson B., Bergh C, Bentham J., Olsson J.-H., Norman M.R., Billig H., Roos P., Hillensjö T. Expression of functional growth hormone receptors in human granulosa cells. Hum. Reprod. 7: 1205, 1992.

    PubMed  CAS  Google Scholar 

  52. Ovesen P., Ingerslev H.J., Ørskov H., Ledet T. Effect of growth hormone on steroidogenesis, insulin-like growth factor-l (IGF-I) and IGF binding protein-1 production and DNA synthesis in cultured human luteinized granulosa cells. J. Endocrinol. 140: 313, 1994.

    PubMed  CAS  Google Scholar 

  53. Fowler P.A., Templeton A. Ovarian response to gonadotrophins: effects of growth hormone. Clin. Endocrinol. (Oxf.) 35: 117, 1991.

    CAS  Google Scholar 

  54. Jacobs H.S., Bouchard P., Conway G.S., Homburg R., Lahlou N., Mason B., Ostergaard H., Owen E.J. Role of growth hormone in infertility. Horm. Res. 36 (suppl. 1): 61, 1991.

    PubMed  Google Scholar 

  55. Shoham Z., Homburg R., Owen E.J., Conway G.S., Ostergaard H., Jacobs H.S. The role of treatment with growth hormone in infertile patients. Baillieres Clin. Obstet. Gynaecol. 6: 267, 1992.

    PubMed  CAS  Google Scholar 

  56. Meirow D., Laufer N., Schenker J.G. Ovulation induction in in vitro fertilization. Gynecol. Endocrinol. 6: 211, 1992.

    PubMed  CAS  Google Scholar 

  57. Jacobs H.S. Growth hormone and ovulation: is there an indication for treatment of infertile women with growth hormone? Horm. Res. 38 (suppl. 1): 14, 1992.

    PubMed  Google Scholar 

  58. Homburg R. Ovulation induction in gonadotrophin-resistant women. Baillieres Clin. Obstet. Gynaecol. 7: 349, 1993.

    PubMed  CAS  Google Scholar 

  59. Katz E. The use of growth hormone treatment for ovulation induction. Curr. Opin. Obstet. Gynecol. 5:234, 1993.

    PubMed  CAS  Google Scholar 

  60. Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging. Endocr. Rev. 14: 20, 1993.

    PubMed  CAS  Google Scholar 

  61. Meirow D., Laufer N., Schenker J.G. Ovulation induction in polycystic ovary syndrome: a review of conservative and new treatment modalities. Eur. J. Obstet. Gynecol. Reprod. Biol. 50: 123, 1993.

    PubMed  CAS  Google Scholar 

  62. Levron J., Lewit N., Erlik Y., Itskovitz-Eldor J. No beneficial effects of human growth hormone therapy in normal ovulatory patients with a poor ovarian response to gonadotropins. Gynecol. Obstet. Invest. 35: 65, 1993.

    PubMed  CAS  Google Scholar 

  63. Lippe B.M., Nakamoto J.M. Conventional and nonconventional uses of growth hormone. Recent Prog. Horm. Res. 48: 179, 1993.

    PubMed  CAS  Google Scholar 

  64. Blumenfeld Z., Amit T. The role of growth hormone in ovulation induction. Ann. Med. 26: 249, 1994.

    PubMed  CAS  Google Scholar 

  65. Ben-Rafael Z., Orvieto R., Feldberg D. The poor-responder patient in an in vitro fertilization—embryo transfer (IVF-ET) program. Gynecol. Endocrinol. 8: 277, 1994.

    PubMed  CAS  Google Scholar 

  66. Homburg R., Ostergaard H. Clinical applications of growth hormone for ovarian stimulation. Hum. Reprod. Update 1: 26, 1995.

    Google Scholar 

  67. Homburg R., Ben-Rafael Z. The place of cotreatment with growth hormone and human menopausal gonadotropin (hMG) in ovarian stimulation. J. Assist. Reprod. Genet. 13: 371, 1996.

    PubMed  CAS  Google Scholar 

  68. Homburg R. Growth hormone and fertility - Clinical studies. Horm. Res. 45: 81, 1996.

    PubMed  CAS  Google Scholar 

  69. Blumenfeld Z, Lunenfeld B. The potentiating effect of growth hormone on follicle stimulation with human menopausal gonadotropin in a panhypopituitary patient. Fertil. Steril. 52: 328, 1989.

    PubMed  CAS  Google Scholar 

  70. Ibrahim Z.H.Z., Matson P.L., Buck P., Lieberman B.A. The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response. Fertil. Steril. 55: 202, 1991.

    PubMed  CAS  Google Scholar 

  71. Owen E.J., Shoham Z., Mason B.A., Ostergaard H., Jacobs H.S. Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertil. Steril. 56: 1104, 1991.

    PubMed  CAS  Google Scholar 

  72. European and Australian Multicenter Study. Cotreatment with growth hormone and gonadotropin for ovulation induction in hypogonadotropic patients: a prospective, randomized, placebo-controlled, dose-response study. Fertil. Steril. 64: 917, 1995.

    Google Scholar 

  73. Volpe A., Coukos G., Barreca A., Artini P.G., Minuto F., Giordano G., Genazzani A.R. Ovarian response to combined growth hormone—gonadotropin treatment in patients resistant to induction of superovulation. Gynecol. Endocrinol. 3: 125, 1989.

    PubMed  CAS  Google Scholar 

  74. Hughes S.M., Huang Z.H., Morris I.D., Matson P.L., Buck P., Lieberman B.A. A double-blind cross-over controlled study to evaluate the effect of human biosynthetic growth hormone on ovarian stimulation in previous poor responded to in-vitro fertilization. Hum. Reprod. 9: 13, 1994.

    PubMed  CAS  Google Scholar 

  75. Bergh C, Hillensjö T., Wikland M., Nilsson L., Borg G., Hamberger L. Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertil. Steril. 62: 113, 1994.

    PubMed  CAS  Google Scholar 

  76. Dor J., Seidman D.S., Amudai E., Bider D., Levran D., Mashiach S. Adjuvant growth hormone therapy in poor responded to in-vitro fertilization: a prospective, randomized, placebo-controlled, double-blind study. Hum. Reprod. 10: 40, 1995.

    PubMed  CAS  Google Scholar 

  77. Shaker A.G., Fleming R., Jamieson M.E., Yates R.W.S., Coutts J.R.T. Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responded. Fertil. Steril. 58: 919, 1992.

    PubMed  CAS  Google Scholar 

  78. Levy T., Limor R., Villa Y., Eshel A., Eckstein N., Vagman I., Lidor A., Ayalon D. Another look at cotreatment with growth hormone and human menopausal gonadotrophins in poor ovarian responders. Hum. Reprod. 8: 834, 1993.

    PubMed  CAS  Google Scholar 

  79. Owen E.J., West C, Mason B.A., Jacobs H.S. Cotreatment with growth hormone of sub-optimal responders in IVF-ET. Hum. Reprod. 6:524, 1991.

    PubMed  CAS  Google Scholar 

  80. Hugues J.-N., Torresani T., Herve F., Martin-Pont B., Tamboise A., Santarelli J. Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder women. Fertil. Steril. 55: 945, 1991.

    PubMed  CAS  Google Scholar 

  81. Garcia J.E., Jones G.S., Acosta A.A., Wright G. jr. Human menopausal gonadotropin human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II. Fertil. Steril. 39: 174, 1983.

    PubMed  CAS  Google Scholar 

  82. Ben-Rafael Z., Feldberg D. The poor-responder patient in an in vitro fertilization-embryo transfer program. J. Assist. Reprod. Genet. 10: 118, 1993.

    PubMed  CAS  Google Scholar 

  83. Cassar J., Verco CG., Joplin G.F. Successful pregnancy induced by human menopausal gonadotropin in a patient with growth hormone deficiency and primary amenorrhea: a case report. Br. J. Obstet. Gynaecol. 87: 337, 1980.

    PubMed  CAS  Google Scholar 

  84. Dawood M.Y., Jarrett J.C., Choe J.K. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins. Fertil. Steril. 38: 415, 1982.

    PubMed  CAS  Google Scholar 

  85. Homburg R., Eshel A., Abdalla HJ., Jacobs H.S. Growth hormone facilitates ovulation induction by gonadotrophins. Clin. Endocrinol. 29: 113, 1988.

    CAS  Google Scholar 

  86. Homburg R., West C, Torresani T., Jacobs H.S. A comparative study of single-dose growth hormone therapy as an adjuvant to gonadotropin treatment for ovulation induction. Clin. Endocrinol. 32: 781, 1990.

    CAS  Google Scholar 

  87. Burger H.G., Kovacs G.T., Poison D.M., McDonald J., McCloud P.I., Harrop M., Colman P., Healy D.L. Ovarian sensitization to gonadotrophins by human growth hormone. Persistence of the effect beyond the treated cycle. Clin. Endocrinol. (Oxf.) 35: 119, 1991.

    CAS  Google Scholar 

  88. Homburg R., West C, Ostergaard H., Jacobs H.S. Combined growth hormone and gonadotropin treatment for ovulation induction in patients with non-responsive ovaries. Gynecol. Endocrinol. 5: 33, 1991.

    PubMed  CAS  Google Scholar 

  89. Volpe A., Coukos G., Artini P.G., Silferi M., Petraglia F., Boghen M., D’Ambrogio G., Genazzani A.R. Pregnancy following combined growth hormone-pulsatile GnRH treatment in a patient with hypothalamic amenorrhea. Hum. Reprod. 5: 345, 1990.

    PubMed  CAS  Google Scholar 

  90. Adams J., Franks S., Poison D.W., Mason H.D., Abdulwahid N., Tucker M., Morris D.V., Price J., Jacobs H.S. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 2: 1375, 1985.

    PubMed  CAS  Google Scholar 

  91. Volpe A., Artini P.G., Barreca A., Minuto F., Coukos G., Genazzani A.R. Effects of growth hormone administration in addition to gonadotrophins in normally ovulating women and polycystic ovary syndrome (PCO) patients. Hum. Reprod. 7: 1347, 1992.

    PubMed  CAS  Google Scholar 

  92. Homburg R., Levy T., Ben-Rafael Z. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial. Hum. Reprod. 10: 2550, 1995.

    PubMed  CAS  Google Scholar 

  93. Quigley M., Rakoff J.S., Yen S.S.C. Increased luteinizing hormone. Sensitivity to dopamine inhibition in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 52: 231, 1981.

    PubMed  CAS  Google Scholar 

  94. Shoupe D., Lobo R. Evidence for an altered cathecolamine metabolism in polycystic ovary syndrome. Am. J. Obstet. Gynecol. 150: 566, 1984.

    PubMed  CAS  Google Scholar 

  95. Cumming D.C, Reid R.L., Quigley M. Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 20: 643, 1984.

    CAS  Google Scholar 

  96. Wortsman J., Wehrenberg W.B., Gavin III J.R., Allen J.P. Elevated levels of β-endorphin and γ3-melanocyte stimulating hormone in the polycystic ovarian syndrome. Obstet. Gynecol. 63: 630, 1984.

    PubMed  CAS  Google Scholar 

  97. Anaplitou L.G., Syrygos K., Panayotakopoulos G., Kalos A., Batrinos M.L. Paradoxical growth hormone response following thyroid-stimulating hormone administration in the polycystic ovarian syndrome. Horm. Res. 31: 119, 1989.

    Google Scholar 

  98. Chang R.J., Nakamura R.M., Judd H.L., Kaplan S.A. Insulin resistance in nonobese patients with polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 57: 356, 1983.

    PubMed  CAS  Google Scholar 

  99. Lanzone A., Fulghesu A.M., Pappalardo S., Proto C, Le Donne M., Andreani C.L., Muscatello R., Caruso A., Mancuso S. Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism. Gynecol. Obstet. Invest. 29: 149, 1990.

    PubMed  CAS  Google Scholar 

  100. Burghen G.A., Givens J.R., Kitabchi A.E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 50: 113, 1980.

    PubMed  CAS  Google Scholar 

  101. Urdl W. Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C. Arch. Gynecol. Obstet. 243: 13, 1988.

    PubMed  CAS  Google Scholar 

  102. Artini P.G., Battaglia C, D’Ambrogio G., Barreca A., Droghini F., Volpe A., Genazzani A.R. Relationship between human oocyte maturity, fertilization and follicular fluid growth factors. Hum. Reprod. 9: 902, 1994.

    PubMed  CAS  Google Scholar 

  103. Hughes S.M., Huang Z.H., Matson P.L., Buck P., Lieberman B.A., Morris I.D. Clinical and endocrinological changes in women following ovulation induction using buserelin/acetate human menopausal gonadotrophin augmented with biosynthetic human growth hormone. Hum. Reprod. 7: 770, 1992.

    PubMed  CAS  Google Scholar 

  104. Younis J.S., Simon A., Koren R., Dorembus D., Schenker J.G., Laufer N. The effect of growth hormone supplementation on in-vitro fertilization outcome: a prospective randomized placebo controlled double-blind study. Fertil. Steril. 58: 575, 1992.

    PubMed  CAS  Google Scholar 

  105. Tapanainen J., Martikainen H., Voutilainen R., Orava M., Ruokonen A., Rönnberg L. Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertil. Steril. 58: 726, 1992.

    PubMed  CAS  Google Scholar 

  106. Tzeng CR., Chien L.W., Cheng Y.F., Chang S.R., Chen A.C. Enhancement of IVF pregnancy rates by cotreatment with low dose growth hormone. J. Assist. Reprod. Genet. 10 (Suppl): 111, 1993.

    Google Scholar 

  107. Volpe A., Coukos G., Barreca A., Giordano G.. Artini P.G., Genazzani A.R. Clinical use of growth hormone-releasing factor for induction of superovulation. Hum. Reprod. 6: 1228, 1991.

    PubMed  CAS  Google Scholar 

  108. Tulandi T., Falcone T., Guyda H., Hemmings R., Billiar R., Morris D. Effect of synthetic growth hormone-releasing factor in women treated with gonadotrophin. Hum. Reprod. 8: 525, 1993.

    PubMed  CAS  Google Scholar 

  109. Genazzani A.R., Artini P.G., Battaglia C, Droghini F., Mancini A.C., D’Ambrogio G. Clinical effects of GRF plus pFSH in poor-responder patients. In: Andreoli M., Shields M. (Eds.), Highlignts in molecular and clinical endocrinology, Frontiers in Endocrinology. Ares-Serono Symposia Publications, Rome, 1994, vol. 9, p. 249.

    Google Scholar 

  110. Jørgensen J.O. Human growth hormone replacement therapy: pharmacological and clinical aspects. Endocr. Rev. 12: 189, 1991.

    PubMed  Google Scholar 

  111. Blumenfeld Z., Dirnfeld M., Gonen Y., Abramovici H. Growth hormone cotreatment for ovulation induction may enhance conception in the cotreatment and succeeding cycles, in clonidine negative but not clonidine positive patients. Hum. Reprod. 9: 209, 1994.

    PubMed  CAS  Google Scholar 

  112. Ituarte E.A., Petrini J., Hershman J.M. Acromegaly and colon cancer. Ann. Intern. Med. 101: 627, 1984.

    PubMed  CAS  Google Scholar 

  113. Ogilvy-Stuart A.L., Shalet S.M. Tumour occurrence and recurrence. Horm. Res. 38 (suppl. 1): 50, 1992.

    PubMed  Google Scholar 

  114. Parker M.L., Hammond J.M., Daughaday W.H. The arginine provocative test: an aid in the diagnosis of hyposomatotropism. J. Clin. Endocrinol. Metab. 27: 1129, 1967.

    PubMed  CAS  Google Scholar 

  115. Ghigo E., Goffi S., Nicolosi M., Arvat E., Valente F., Mazza E., Ghigo M.C, Camanni F. Growth hormone (GH) responsiveness to combined administration of arginine and GH-reieasing hormone does not vary with age in man. J. Clin. Endocrinol. Metab. 71: 1481, 1990.

    PubMed  CAS  Google Scholar 

  116. Davis T.M.E., Burrin J.M., Bloom S.R. Growth hormone (GH) release in response to GH-releasing hormone in man is 3-fold enhanced by galanin. J. Clin. Endocrinol. Metab. 65: 1248, 1987.

    PubMed  CAS  Google Scholar 

  117. Fass B., Lippe B.M., Kaplan S.A. Relative usefulness of three growth hormone stimulation screening tests. Am. J. Dis. Child. 133: 931, 1979.

    PubMed  CAS  Google Scholar 

  118. Shibasaki T., Hotta M., Masuda A., Imaki T., Obara N., Demura H., Ling N., Shizume K. Plasma GH response to GRH and insulin induced hypoglycemia in man. J. Clin. Endocrinol. Metab. 60: 1265, 1985.

    PubMed  CAS  Google Scholar 

  119. Lancranjan I., Marbach P. New evidence for growth hormone modulation by alpha-adrenergic system in man. Metabolism 26: 1225, 1977.

    PubMed  CAS  Google Scholar 

  120. Slover R.H., Klingensmith G.J., Gotlin R.W., Radcliffe J. A comparison of Clonidine and standard provocative agents of growth hormone. Am. J. Dis. Child. 138: 314, 1984.

    PubMed  CAS  Google Scholar 

  121. Frasier S.D. A review of growth hormone stimulation tests in children. Pediatrics 53: 929, 1974.

    PubMed  CAS  Google Scholar 

  122. Moll G.W. jr., Rosenfield R.L., Fang V.S. Administration of low-dose estrogen rapidly and directly stimulates growth hormone production. Am. J. Dis. Child. 140: 124, 1986.

    PubMed  Google Scholar 

  123. Arends J., Wagner W.-L, Willms B.L. Cholinergic muscarinic receptor blockade suppresses arginine- and exercise-induced growth hormone secretion in type I diabetic subjects. J. Clin. Endocrinol. Metab. 66: 389, 1988.

    PubMed  CAS  Google Scholar 

  124. Alba-Roth J., Müller O.A., Schopohl J., von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Endocrinol. Metab. 67: 1186, 1988.

    PubMed  CAS  Google Scholar 

  125. Menashe Y., Lunenfeld B., Pariente C, Frenkel Y., Mashiach S. Can growth hormone increase, after Clonidine administration, predict the dose of human menopausal hormone needed for induction of ovulation? Fertil. Steril. 53: 432, 1990.

    PubMed  CAS  Google Scholar 

  126. Ovesen P., Møller J., Møller N., Christiansen J.S., Ørskov H., Jørgensen J.O.L. Growth hormone secretory capacity and serum insulin-like growth factor I levels in primary infertile, anovulatory women with regular menses. Fertil. Steril. 57: 97, 1992.

    PubMed  CAS  Google Scholar 

  127. Salat-Baroux J., Rotten D., Alvarez S., Antoine J.M. Comparison of growth hormone responses to growth hormone-releasing factor and Clonidine in women with normal or poor ovarian response to gonadotropin stimulation. Fertil. Steril. 60: 791, 1993.

    PubMed  CAS  Google Scholar 

  128. Stone B.A., Marrs R.P. Ovarian response to menopausal gonadotropins in groups of patients with differing basal growth hormone levels. Fertil. Steril. 58: 32, 1992.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Artini, P.G., de Micheroux, A.A. & D’Ambrogio, G. Growth hormone cotreatment with gonadotropins in ovulation induction. J Endocrinol Invest 19, 763–779 (1996). https://doi.org/10.1007/BF03347881

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347881

Key words

Navigation